General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-10 | 2024-03 | 0 | 0.23 | N/A | N/A |
2024-03-28 | 2023-12 | 0 | -0.57 | N/A | N/A |
2023-11-09 | 2023-09 | -1.05 | -1.03 | 0.02 | 1.90% |
2023-08-10 | 2023-06 | -1.23 | -1.04 | 0.19 | 15.45% |
2023-05-12 | 2023-03 | 0 | -1.22 | N/A | N/A |
2023-03-30 | 2022-12 | -1.44 | -1.14 | 0.3 | 20.83% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-02-06 | HC Wainwright & Co. | Upgrade | Buy | |
2022-03-29 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2017-03-21 | CLARKE ROBERT W PH.D. | Chief Executive Officer | 4.53K | Conversion of Exercise of derivative security |
2014-05-08 | FRENCH GREGORY M | Director | 58.00K | Stock Award(Grant) |
2018-04-02 | GILLIS STEVEN | Director | 0.00 | Purchase |
2017-03-21 | HAVA DAVID L | Officer | 2.26K | Conversion of Exercise of derivative security |
2018-04-02 | IWICKI MARK T. | Director | 307.00K | Purchase |
2015-06-15 | MAKI DAVID | Director | 0.00 | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Sabby Management, LLC | 184.07K | 493.32K | 5.04% |
2023-06-29 | Renaissance Technologies, LLC | 109.01K | 292.15K | 2.98% |
2023-06-29 | Blackrock Inc. | 54.90K | 147.13K | 1.50% |
2023-06-29 | Geode Capital Management, LLC | 24.62K | 65.99K | 0.67% |
2023-06-29 | Vanguard Group Inc | 21.39K | 57.33K | 0.59% |
2023-06-29 | State Street Corporation | 13.95K | 37.37K | 0.38% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 21.39K | 57.33K | 0.59% |
2023-05-30 | Fidelity Extended Market Index Fund | 13.78K | 37.60K | 0.38% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Fund | 9.70K | 26.00K | 0.27% |
2023-05-30 | Fidelity Total Market Index Fund | 4.45K | 12.16K | 0.12% |
2023-05-30 | Fidelity Series Total Market Index Fund | 4.16K | 11.34K | 0.11% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 2.22K | 6.06K | 0.06% |
Split | Date |
---|---|
1 : 20 | 2022-03-01 |
1 : 10 | 2019-02-06 |
4 : 10 | 2015-06-16 |
Just add another 6000 more. I’ll say it’s worth the risk
A respiratory drug maker that lost ground during a respiratory pandemic. I’m a long hold that is at my patience limit. They need to be booted from the main exchange.
This thing isn’t looking good
Test again vvv hi
Jjgggvuuffjl
Test ygrevbj
Test post
earning report is on 3/25 pre market
Volume seems very low for this run.
Like to apologize to my fellow longs here...I bought more.
Tryna get to 50k shares tomorrow. See if she fills...
That’s funny
When it happens, won’t be slow. Been here too long to leave now.
Market at all time high and folks are short on this? Can’t fix stupid and they deserve what’s coming.
Weird stock.